NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance (1) and reaffirmed its October 29, 2024 full-year 2024 guidance (1). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback